A Closer Look at Immunotherapy

Cancer is challenging, but advances in treatment continue to offer new hope. Immunotherapy helps the immune system find and destroy cancer cells. Instead of targeting cancer directly, it strengthens the body’s natural defenses so they can recognize and attack the disease more effectively. This differs from chemotherapy and radiation, which kill cancer cells outright. Immunotherapy has changed how many cancers are treated and continues to create new possibilities for patients.

What Is Cancer Immunotherapy?

Immunotherapy teaches the immune system to better recognize cancer cells and respond more aggressively. There are several types, including cancer vaccines, monoclonal antibodies, immune checkpoint inhibitors, and T-cell therapies. Each works differently but shares the same goal: helping the immune system respond more effectively to cancer. For many patients, immunotherapy has shown success even when other treatments have not.

Different Types of Immunotherapy

Cancer Vaccines

Cancer vaccines help the immune system identify and destroy cancer cells. Unlike routine vaccines that prevent disease, cancer vaccines are usually given after a diagnosis. They introduce antigens that guide the immune system to its target.

There are two types. Preventive vaccines, such as HPV and Hepatitis B vaccines, help stop cancers linked to those viruses. Treatment vaccines are given after a cancer diagnosis to strengthen the immune response. Dosing and delivery vary based on the specific vaccine and patient needs.

T-Cell Transfer Therapy

T-cell therapy uses a patient’s own immune cells to fight cancer more effectively. Doctors remove T-cells, select the ones already trying to attack the cancer, and grow large numbers of them in a lab. These strengthened cells are returned to the body to target cancer cells more aggressively. This therapy is often paired with other treatments.

Monoclonal Antibodies

Monoclonal antibodies are lab-made proteins designed to attach to markers on cancer cells. Once attached, they can block signals that help cancer grow or flag cancer cells for destruction. They are given through an IV and may be used alone or with other treatments.

Immune Checkpoint Inhibitors

Checkpoint inhibitors release natural “brakes” that prevent the immune system from attacking cancer. Cancer often uses these brakes to hide. By blocking them, these drugs help immune cells identify and attack cancer more effectively. They have shown strong results in melanoma, lung cancer, and kidney cancer but require close monitoring for side effects.

Benefits and Risks of Immunotherapy

Immunotherapy uses the body’s natural defenses, may have fewer side effects than chemotherapy, and can help when other treatments fail. However, boosting the immune system can sometimes cause it to attack healthy tissues. Side effects may include fatigue, nausea, rashes, cough, or inflammation in organs such as the lungs or heart. Not every patient will respond, so it’s important to talk with a provider about risks and benefits.

Potential Side Effects

Side effects depend on the therapy and how the body reacts. Common symptoms include fatigue, fever, chills, nausea, dizziness, or changes in blood pressure. Some patients may experience swelling, shortness of breath, or skin reactions. Rare but serious reactions can affect organs. Patients should report symptoms quickly so treatment can be adjusted.

Effectiveness in Cancer Treatment

Immunotherapy has helped many patients reduce tumor size and, in some cases, achieve remission. Results vary based on cancer type, stage, and overall health. Immunotherapy is often combined with other treatments as part of a full care plan. While it does not work for everyone, it has made major strides for cancers that were once difficult to treat.

Key Takeaways

Immunotherapy strengthens the body’s immune system to help it detect and destroy cancer cells. It offers a targeted approach that can work when other treatments fall short. Each type of immunotherapy supports the immune response differently, and results vary from person to person. Talking with your care team is the best way to understand how immunotherapy fits into your treatment plan.